Merz Therapeutics and Teijin Secure Japan Approval for XEOMIN®
TOKYO, Japan and FRANKFURT, Germany, June 19, 2026 Teijin Pharma Limited and Merz Therapeutics GmbH have announced that Japan’s...
specialty pharma
Advertisement
SERB and Hansa Biopharma Strengthen Rare Disease Portfolio With Idefirix Agreement
BRUSSELS, Belgium, May 19, 2026 SERB Pharmaceuticals and Hansa Biopharma have announced a strategic €115 million licensing agreement granting...
CMP Pharma Introduces Alcohol-Free Norliqva for Pediatrics
FARMVILLE, N.C., April 20, 2026 CMP Pharma, Inc. has announced the availability of a newly reformulated Norliqva® (amlodipine) oral...
Recordati Confirms CVC Interest in Major Pharma M&A Deal
MILAN, Italy, March 26, 2026 Recordati S.p.A. has confirmed receiving a non-binding indication of interest from CVC Capital Partners...
Advertisement
